Jalandoni, Norma C.
HRN: 09-39-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/24/2024
03/31/2024
IV
2.25g
Q6
Urosepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes